PharmGen Science, Inc. engages in the development and production of medicaments. It operates through the following business divisions: ETC Drug, OTC Drug, Obesity Drug and Health Food. The company was founded on August 22, 1966 and is headquartered in Hwaseong, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company